Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways
- PMID: 30576770
- DOI: 10.1016/j.jep.2018.12.023
Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways
Abstract
Ethnopharmacological relevance: Advanced breast cancer frequently metastasizes to the bone, resulting in patient morbidity and mortality. The interaction of tumor cells with osteoclasts and osteoblasts seriously affects the occurrence and development of bone metastasis in breast cancer. The signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways plays a significant role in the context of bone metastasis.
Aim of the study: Although Wenshen Zhuanggu (WSZG) formula efficiently decreased the risk of bone metastases in tumor-bearing mice, it remains unclear how WSZG formula regulates the interaction of cancer cells with osteoclasts and osteoblasts in bone metastasis of breast cancer.
Materials and methods: In this study, we investigated the role of WSZG formula in the progress of bone metastasis in breast cancer and focused on the cell-cell interactions of tumor cells with osteoclasts and osteoblasts. Western blotting and quantitative real-time PCR were utilized to evaluate the inhibitory activities of WSZG formula on Jagged1 expression both in vivo and in vitro. Osteoblast co-culture and osteoclastogenesis co-culture were applied to analyze the effects of WSZG formula on the interaction of tumor cells with osteoclasts and osteoblasts. A breast cancer xenograft model was also used to test the inhibitory effects of WSZG formula on bone metastasis in breast cancer.
Results: WSZG formula decreased Jagged1 expression in osteolytic lesions in the breast cancer xenograft model. Additionally, WSZG formula decreased Jagged1 expression in tumor cell culture alone or co-culture with pre-osteoclasts and osteoblasts. In addition, WSZG formula decreased Jagged1 expression in Jagged1-overexpressing tumor cells.
Conclusion: The results of this study suggest that WSZG formula mitigates breast cancer bone metastasis through the Jagged1/Notch signaling pathway mediated by TGF-β and IL-6.
Keywords: Bone metastasis; Breast cancer; IL-6; Jagged1/Notch signaling; TGF-β; Wenshen Zhuanggu formula.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model.Acta Pharmacol Sin. 2017 Oct;38(10):1369-1380. doi: 10.1038/aps.2017.13. Epub 2017 Apr 17. Acta Pharmacol Sin. 2017. PMID: 28414206 Free PMC article.
-
Anti-metastatic effect and mechanisms of Wenshen Zhuanggu Formula in human breast cancer cells.J Ethnopharmacol. 2015 Mar 13;162:39-46. doi: 10.1016/j.jep.2014.12.036. Epub 2014 Dec 29. J Ethnopharmacol. 2015. PMID: 25554638
-
WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.Biomed Pharmacother. 2020 Jan;121:109617. doi: 10.1016/j.biopha.2019.109617. Epub 2019 Nov 22. Biomed Pharmacother. 2020. PMID: 31810139
-
Parathyroid hormone-related protein and bone metastases.Cancer. 1997 Oct 15;80(8 Suppl):1572-80. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.3.co;2-d. Cancer. 1997. PMID: 9362424 Review.
-
Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.Int J Mol Sci. 2019 Jan 17;20(2):384. doi: 10.3390/ijms20020384. Int J Mol Sci. 2019. PMID: 30658428 Free PMC article. Review.
Cited by
-
Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer.Toxicol Res (Camb). 2020 Aug 13;9(4):544-551. doi: 10.1093/toxres/tfaa053. eCollection 2020 Jul. Toxicol Res (Camb). 2020. PMID: 32905216 Free PMC article.
-
Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer.BMC Complement Med Ther. 2021 Jul 5;21(1):191. doi: 10.1186/s12906-021-03365-4. BMC Complement Med Ther. 2021. PMID: 34225726 Free PMC article.
-
Biological and Clinical Aspects of Metastatic Spinal Tumors.Cancers (Basel). 2022 Sep 22;14(19):4599. doi: 10.3390/cancers14194599. Cancers (Basel). 2022. PMID: 36230523 Free PMC article. Review.
-
Bridging molecular insights and clinical application: non-coding RNAs, targeted drug delivery, and metastatic breast cancer therapy.Discov Oncol. 2025 Jul 26;16(1):1413. doi: 10.1007/s12672-025-03090-1. Discov Oncol. 2025. PMID: 40715915 Free PMC article. Review.
-
Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer.Int J Mol Sci. 2023 Sep 30;24(19):14777. doi: 10.3390/ijms241914777. Int J Mol Sci. 2023. PMID: 37834225 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials